Truqap is really a kinase inhibitor that works by blocking pathways that aid the cancer cells survive and develop, so lowers cancer progress. Truqap is from a class of medicines named an AKT inhibitor. Truqap gained FDA acceptance on November seventeen, 2023, following optimistic benefits with the CAPItello-291 Stage III https://jinnahc332nzj5.wikiconversation.com/user